Quantcast

Posts related to ‘AZN’

global economy

UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More

Total return is always the name of the game when it comes to investing success. Stocks that pay dividends on a regular basis help smooth out the rough spots when ...
Read Full Story »
health care

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States ...
Read Full Story »
Money, US, $100 bills

UBS Has Top Dividend Ruler Stocks from Around the World (AZN, TOT, INTC, BNS, NU, SNY, OXY, UPS, JNJ, CLX)

Investors love dividends, and this component of investing plays a very important part of the total return through time. Buying stocks that combine solid and growing dividends with a potential ...
Read Full Story »
Wall St Bull statue

Top Key Call Stocks from UBS Global Ideas of the Week (LOW, TWX, BUD, APC, KEY, AZN, RIO, UBS)

When the holidays wound down and we started off 2013, all the Wall St. firms started to put out their top stock picks for the year. We covered those various ...
Read Full Story »
Pills

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’ ...
Read Full Story »
Money, US, $100 bills

Big Dividend Yields from UBS Dividend Ruler Stock List (UBS, AZN, TOT, INTC, BTI, RTN, TD, NU, UL, NEE, JNJ)

S&P 500 dividend growth continues to outpace earnings growth, a trend that likely will continue for a few more years. Low yields on fixed income alternatives and historically low dividend ...
Read Full Story »
Media summaries

Media Digest (2/1/2013) Reuters, WSJ, FT, Bloomberg

PMI data from Asia shows the slowing of economies there. (Reuters) A private equity buyout of Dell Inc. (NASDAQ: DELL) may be only week away. (Reuters) The cost of beef ...
Read Full Story »
pills

Drug Maker Staging a Comeback After Yesterday’s Debacle

Drug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment it was developing with AstraZeneca plc (NYSE: AZN) did not ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AMD, AMGN, AAPL, ARIA, AZN, BIIB, CELG, DELL, ERIC, FITB, INTC, IP, ITRI, PHG, LULU, NRG, PNRA, PNC, PGR, SNY, STX, S, WFC, RF)

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Advanced Micro Devices Inc. (NYSE: AMD) raised to Neutral from Sell ...
Read Full Story »

24/7 Wall St. Closing Bell — August 20, 2012: Markets Uninspired Again (SCCO, BRCD, AZN, ROST, BEBE, LOW, COCO, URBN, BBY, TECD, BKS, ADI, DELL, MDT, VLO, CVH, AET, LDK)

The three major US stock indexes opened lower this morning following a negative reaction by a government official to a weekend report that Germany would support a sovereign bond-buying plan ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AGU, AZN, BEBE, BRCD, CHUY, PB, QSII, ROST, SCCO, STO, STEM, TI, VNTV)

These are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Monday morning. Agrium Inc. (NYSE: AGU) named as Bull of ...
Read Full Story »

Amarin Shares Fall Despite Regulatory OK

Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp. (NASDAQ: AMRN) announced approval by the FDA for Vascepta to ...
Read Full Story »

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for the first quarter of 2012. The top five sellers include ...
Read Full Story »

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the ...
Read Full Story »

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in ...
Read Full Story »